In the frontal cortex, synaptophysin mRNA levels showed non-significant reductions in both CX3CR1-deficient mice (0.91 ± 0.06-fold) and AD mice (0.80 ± 0.16-fold) compared to wild-type controls (Figure 7B). This evidence concerns the gene CX3CR1 and Alzheimer disease.